Rouzel Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 13-12-2024
- Paid Up Capital ₹ 2.50 M
as on 13-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.67 Cr
as on 13-12-2024
- Satisfied Charges ₹ 4.00 M
as on 13-12-2024
- Revenue 37.49%
(FY 2022)
- Profit 56.40%
(FY 2022)
- Ebitda 196.51%
(FY 2022)
- Net Worth 24.21%
(FY 2022)
- Total Assets 35.94%
(FY 2022)
About Rouzel Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.67 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Sharma and Vivek Singla serve as directors at the Company.
- CIN/LLPIN
U24232CH2011PTC032830
- Company No.
032830
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rouzel Pharma Private Limited offer?
Rouzel Pharma Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Cardiovascular Drugs & Medication, Kidney Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Rouzel Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Sharma  | Managing Director | 23-Mar-2011 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Singla | Director | 23-Mar-2011 | Current |
Financial Performance of Rouzel Pharma.
Rouzel Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.49% increase. The company also saw a substantial improvement in profitability, with a 56.4% increase in profit. The company's net worth Soared by an impressive increase of 24.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rouzel Pharma?
Unlock access to Rouzel Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Mar 2023 | ₹1.25 Cr | Open |
Others Creation Date: 31 Dec 2016 | ₹3.20 M | Open |
Icici Bank Limited Creation Date: 13 Oct 2015 | ₹1.00 M | Open |
How Many Employees Work at Rouzel Pharma?
Unlock and access historical data on people associated with Rouzel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rouzel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rouzel Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
